HK2 and neoplasm: A cadre of tumor-suppressive miRNAs—miR-3662, miR-199a-5p, miR-125a, miR-885-5p counter this shift by directly targeting HIF1A or the rate-limiting enzyme Hexokinase 2 (HK2).